Mike McCormick is Executive Chairman and Co-Founder of CorRen Medical and a seasoned medical technology executive with more than three decades of leadership experience spanning product development, commercialization, corporate strategy, and value creation.

Throughout his career, Mike has founded, scaled, and led both public and private medical technology companies, with extensive experience in commercialization, operational execution, capital formation, and strategic transactions.

Mike currently serves as President and Chief Executive Officer of Nuwellis, Inc. (Nasdaq: NUWE). Previously, he served as President and CEO of Osprey Medical, where he led the development and commercialization of technologies designed to reduce contrast-related kidney injury during cardiovascular procedures. His prior leadership roles also include CEO of Anulex Technologies, President of Centerpulse Spine-Tech, and senior commercial leadership positions at Boston Scientific.

Mike brings to CorRen extensive experience building and commercializing innovative medical technologies, developing clinical markets, raising capital, and creating strategic value for shareholders.

David has held executive product, technology, and organizational development leadership roles at several firms in the med tech sector. Most recently and for the last 7 years, he was Chief Technology Officer at Nuwellis (formerly CHF Solutions). Before Nuwellis, he served as the Vice President of Engineering at Senseonics, Inc. focusing on the development of an implantable glucose sensing system for the management of diabetes.  Prior to that, he was Chief Technology Officer at Biomedix where he led the company’s development of hardware, software, and web-based service solutions for the management of patients with vascular disease. David was a co-founder and board member of Biomedix and served as the VP of Engineering from 1997 to 2002.

David has also served as VP of Engineering and Technology for Image Sensing Systems, Inc. and Bosch/Telex Communications, Inc. where he directed technical activity at multiple domestic and international locations with a strong focus on employee development, innovation and on-time delivery. He is the recipient of multiple device patents and holds a BS in Electronics Engineering from the State University of New York as well as an MS in Management, and an MS in Medical Physics from the University of Minnesota.

Mr. Erb is currently the co-founder of two private medical device companies, CorRen Medical and AcQumen Medical.  He is Chairman of the Board for Nuwellis Inc., a public NASDAQ company that is a global medical device company focused in cardiology. 

Mr. Erb previously served as Chairman and CEO of Nuwellis, Inc. (formerly CHF Solutions, Inc.) from 2015 until July of 2021 and from February 2025 to June of 2026.  He was previously Chairman of the Board for Vascular Solutions, Inc., a public NASDAQ company acquired by Teleflex in 2017; Chairman of the Board of Osprey Medical, a public Australian Stock Exchange company; a member of the board of directors for MiroMatrix, Inc., a public NASDAQ company; a board member of SenoRx, Inc., a public NASDAQ company acquired by CR Bard in 2010; and a board member of CryoCath Technologies, Inc., a public Canadian company listed on the Toronto Exchange, acquired by Medtronic 2008.

From 2001 to 2007 Mr. Erb was Chief Executive Officer of CHF Solutions, Inc., a private company focused on the treatment of heart failure and acquired by Gambro in 2010.  From 1997 through 2001, Mr. Erb was President and Chief Executive Officer of IntraTherapuetics, Inc., a private company acquired by Sulzer Medica in 2001.  Other previous executive experience includes Vice President of Operations for Schneider Worldwide, a division of Pfizer, Inc.; ten years with Johnson & Johnson’s Iolab Division; and started his career with American Hospital Supply Corporation.

Mr. Erb has bachelor’s degree in business administration from California State University, Fullerton.

Nancy is the Principal at Ness & Associates, Inc., a financial consulting company founded in 1996. Nancy has been acting CFO for over 50 private and publicly traded healthcare companies, where her responsibilities have included raising equity, debt, and bridge financing, managing operating funds, human resources, budgets, financial forecast modeling, and tax returns. Nancy was CFO for Anulex Technologies from 2005-2010 and early in her career was an accountant at Northwest Airlines (Delta), and Home Styles Publishing and Marketing.

Nancy earned a BA in Accounting and Business Administration from the University of St. Thomas and holds a Certified Public Accountant license.

Rod has over 30 years of medical device experience in Research & Development.  Prior to CorRen Medical, Rod was Vice President of Research and Development at Osprey Medical, Vice President of Research and Development for Anulex Technologies and Director of Product Development for Centerpulse Spine-Tech (Zimmer Spine).  Rod also developed orthopedic implants and instrumentation at Wright Medical Technology.  Prior to medical devices, Rod developed smart weapons at Honeywell and Alliant Techsystems. 

Rod is the recipient of multiple device patents and holds a Bachelor of Mechanical Engineering with an emphasis in Biomedical Engineering from the University of Minnesota.    

Melanie Hess brings more than 25 years of medical industry experience gaining regulatory approvals worldwide, including over a decade dedicated to guiding medical device companies from start-up through first commercialization. She specializes in regulatory strategy, quality systems, compliance, and global regulatory affairs. 

As VP of Regulatory, Quality, and Compliance at Endogenex, Inc., Melanie leads the regulatory strategy and quality infrastructure underpinning the company’s path to market.

Prior to Endogenex, Melanie held leadership positions at Osprey Medical, American Medical Systems, Endo Pharmaceuticals (AMS), and St. Jude Medical. She began her career as a medical and surgical intensive care nurse, spending eight years at the bedside before transitioning into industry, a foundation that informs her patient-centered approach to device development.

Melanie holds a Bachelor of Science in Nursing from the University of Minnesota, Minneapolis, and an MBA from the University of Phoenix.

Dr. Summers, Billy S. Guyton Professor Emeritus, is a native of Gulfport Mississippi and graduated from the University of Southern Mississippi magna cum laude in mathematics in 1977. He received his medical degree from the University of Mississippi Medical Center in 1981 after which he entered their residency program in internal medicine. Summers then began graduate studies and completed a research fellowship under Drs Arthur C. Guyton and Thomas G. Coleman in the Department of Physiology and Biophysics. Since 1988 he has been a faculty member at the University of Mississippi Medical Center in various roles including Chairman of the Department of Emergency Medicine. He previously served as the Associate Vice Chancellor for Research and holds joint appointments in the Department of Emergency Medicine and the Department of Physiology and Biophysics and is a Fellow of the American College of Emergency Physicians. He has coauthored over 300 publications and received research awards from the American Heart Association and the Society for Academic Emergency Medicine. He is also the recipient of the prestigious Sebetia Ter International Award for Biomedical Research.

During his career, Dr. Summers has been funded by NIH, NASA and several foundations. He was previously the lead scientist for the NASA Digital Astronaut Project and a member of the advisory team for the NASA Cardiovascular Laboratory.

Dr. Ebbini received his PhD from the University of Illinois at Urbana-Champaign in 1990. He is currently a professor in electrical and computer engineering at the University of Minnesota Twin-Cities. His research interests are in signal and array processing with applications to medical ultrasound. He is a fellow of the IEEE and has been active in several IEEE societies, conferences and journals. Dr. Ebbini also served as the President of the International Society for Therapeutic Ultrasound (2012 – 2015) in addition to being a founding member of the Society in 2001. He contributed to both diagnostic and therapeutic aspects of medical ultrasound, including optimal array pattern synthesis for imaging and therapy, temperature imaging, nonlinear contrast agent imaging, high-speed parallel imaging.

Dr. Ebbini pioneered the concept of dual-mode ultrasound array (DMUA) systems for image-guided surgery and other noninvasive interventions such as transcranial neuromodulation. His research team at Minnesota recently demonstrated the real-time use of this technology in a preclinical model of hypertension in vivo, where they have demonstrated the feasibility of forming precise thermal lesions in the carotid body. The technology has also been used to successfully target/ablate atherosclerotic plaques in the femoral artery in human patients under license from the University of Minnesota. Most recently, Dr. Ebbini has been collaborating with colleagues from Neurosurgery to investigate the use of ablative and neuromodulatory applications of transcranial focused ultrasound (tFUS), including potential treatment of glioblastoma. His laboratory is currently investigating a number of novel approaches involving 3D imaging, real-time ultrasound thermometry in vivo, and self-focusing arrays in the presence of strongly scattering objects.

Dr. Ebbini has served on numerous consulting and advisory panels for governmental and private organizations, including NIH, NSF, and NASA. He was a charter member of the NIH Biomedical Imaging Study Section-B and he currently serves as a consultant to the FDA Center for Devices and Radiological Health. He has also served as an associate editor/editorial board member for several journals and a guest editor of three special issues on therapeutic ultrasound.

Dori has more than 15 years of experience in cardiac and critical care devices and has held positions in Research & Development, Engineering, Clinical, and Marketing.  Her areas of expertise include mechanical circulatory support, fluid management, neuromodulation and hemodynamic monitoring.  Dori is the founder and managing director of D Squared Consulting, providing cross-disciplinary support to some of the global leaders in the medical device industry.

Dori has a BS in Mechanical Engineering from Lehigh University and a MSE in Biomedical Engineering from Purdue University, which is complemented by a decade of field clinical experience.